An oligonucleotide or its functional homologue, a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7088 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07H 21/04 (2006.01) C12N 15/63 (2006.01)

Patent

CA 2609067

The invention provides an oligonucleotide with a sequence of SEQ ID NO:1 or its functional homolgue, a composition comprising the same and a method for treating B cell neoplasm by using the oligonucleotide or its functional homologue or the composition comprising the oligonucleotide. The oligonulceotide induces the apoptosis of B cell neoplastic cells, up-regulates CD40 on B cell neoplastic cells and stimulates the production of IL-10 from B cell neoplastic cells.

L~invention concerne un oligonucléotide avec une séquence de SEQ ID NO:1 ou son homologue fonctionnel, une composition le comprenant et un procédé pour le traitement d~une tumeur cancéreuse à lymphocytes B en utilisant l~oligonucléotide ou son homologue fonctionnel ou la composition comprenant l~oligonucléotide. L~oligonucléotide induit l~apoptose des cellules néoplasiques à lymphocytes B, régule par le haut le CD40 sur les cellules néoplasiques à lymphocytes B et stimule la production d~IL-10 à partir des cellules néoplasiques à cellules B.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

An oligonucleotide or its functional homologue, a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with An oligonucleotide or its functional homologue, a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An oligonucleotide or its functional homologue, a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1763140

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.